Please use this identifier to cite or link to this item:
Title: Insulin glargine and its role in glycaemic management of Type 2 diabetes.
Authors: Elrishi, MA
Jarvis, J
Khunti, K
Davies, MJ
First Published: Aug-2008
Citation: EXPERT OPIN DRUG METAB TOXICOL, 2008, 4 (8), pp. 1099-1110
Abstract: Insulin glargine (Lantus) was the first recombinant-DNA long-acting insulin analogue to be licensed for use in the treatment of diabetes mellitus.
DOI Link: 10.1517/17425255.4.8.1099
ISSN: 1742-5255
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Cardiovascular Sciences

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.